This rapid review examines the relationship between price, purity and seven population level measures of drug-related harm and any differences across three drug types.
This report provides an analysis of drug trafficking and its links with organised crime based on the most current evidence and with the support of experts. It exposes the failures of current policies in addressing deep-rooted issues that feed organised crime, levels of violence and...
Dalgarno Institute submission to the Parliamentary Inquiry into Communication Campaigns Targeting Drug and Substance Abuse
This document presents the Dalgarno Institute submission to the Parliamentary Inquiry into Communication Campaigns Targeting Drug and Substance Abuse.
The data presented in this report suggest that countries in Asia have not been able to achieve the frequently reiterated goal of a ‘drug-free’ region nor to ‘eliminate or reduce significantly’ the illicit cultivation, production, trafficking, sale and consumption of drugs.
Like many countries around the world, cannabis use is a reality in New Zealand. The result of the nation's current policy approach damages health, worsens social equity, and drives up crime. The status quo is unacceptable, and this paper examines how New Zealand can do...
In 2017–18, 952 publicly-funded alcohol and other drug treatment services provided just under 210,000 treatment episodes to an estimated 130,000 clients. The four most common drugs that led clients to seek treatment were alcohol, amphetamines, cannabis and heroin. Two-thirds (66%) of all clients receiving treatment...
This report analyses the last thirty years of over-incarceration in closed settings, from prisons to migrant administrative detention and from mandatory treatment to private rehabilitation centers. The paper highlights the responsibility of the State towards people who are incarcerated, and demonstrates how their health and...
This report presents a top-level overview of the drug phenomenon in Europe, covering drug supply and use and public health problems, as well as drug policy and responses.